Welcoming Elizabeth Hernandez to the CNSide Diagnostics Team

by | Oct 20, 2025 | News

CNSide Diagnostics is pleased to announce the addition of Elizabeth Hernandez as Laboratory Operations Coordinator.

Elizabeth brings valuable experience in laboratory management and operational excellence to our growing team — supporting CNSide’s mission to advance precision diagnostics for patients facing central nervous system (CNS) cancers, including leptomeningeal metastases (LM).

As Laboratory Operations Coordinator, Elizabeth will play a key role in supporting daily laboratory activities, quality assurance processes, and coordination across technical and administrative teams. Her expertise will help ensure that our laboratory operations continue to meet the highest standards of accuracy, efficiency, and patient impact.

Growing a Team with Purpose

At CNSide, we’re more than a diagnostics company — we’re a team united by a shared mission to bring clarity and innovation to CNS cancer care. Every new team member strengthens our capacity to translate scientific insight into meaningful clinical solutions for patients and physicians.

We’re excited to welcome Elizabeth to the CNSide family as we continue to expand our operations and prepare for the next phase of growth in precision medicine and neuro-oncology diagnostics.

Learn more about our team, mission, and values: https://hubs.la/Q03P1pqw0

Written By CNSide Diagnostics

undefined

Related Posts

Two New Strategic Executive Hires

Expanding operational and regulatory expertise to support commercialization and growth Plus Therapeutics (NASDAQ: PSTV) today announced two key leadership additions to CNSide Diagnostics, its wholly-owned subsidiary, further strengthening the company’s operational...

read more

Houston Business Journal

Strengthening CNS oncology diagnostics at the heart of America’s largest medical ecosystem CNSide Diagnostics, a subsidiary of Plus Therapeutics (NASDAQ: PSTV), has officially expanded into Levit Green, a premier life sciences innovation campus developed by Hines in...

read more

0 Comments